Empirical Financial Services LLC d.b.a. Empirical Wealth Management decreased its stake in shares of Danaher Corporation (NYSE:DHR – Free Report) by 14.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 18,188 shares of the conglomerate’s stock after selling 3,013 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management’s holdings in Danaher were worth $3,448,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. Enterprise Financial Services Corp lifted its position in shares of Danaher by 1.4% during the fourth quarter. Enterprise Financial Services Corp now owns 3,219 shares of the conglomerate’s stock worth $737,000 after purchasing an additional 46 shares in the last quarter. Kennebec Savings Bank increased its holdings in shares of Danaher by 1.4% in the fourth quarter. Kennebec Savings Bank now owns 3,348 shares of the conglomerate’s stock valued at $766,000 after purchasing an additional 46 shares in the last quarter. Revolve Wealth Partners LLC raised its position in Danaher by 2.6% in the 4th quarter. Revolve Wealth Partners LLC now owns 1,870 shares of the conglomerate’s stock worth $428,000 after purchasing an additional 47 shares during the last quarter. High Note Wealth LLC raised its position in Danaher by 19.2% in the 4th quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock worth $67,000 after purchasing an additional 47 shares during the last quarter. Finally, First Command Advisory Services Inc. lifted its holdings in Danaher by 4.4% during the 4th quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock worth $253,000 after buying an additional 47 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.
Danaher Price Performance
Shares of DHR stock opened at $199.06 on Wednesday. The firm’s 50 day moving average price is $181.51 and its two-hundred day moving average price is $198.83. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The stock has a market cap of $140.89 billion, a PE ratio of 38.50, a PEG ratio of 2.55 and a beta of 0.79.
Danaher Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio is currently 30.95%.
Analyst Upgrades and Downgrades
A number of research analysts have commented on the company. Wells Fargo & Company decreased their price objective on Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 22nd. TD Cowen dropped their target price on Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Evercore reaffirmed an “outperform” rating and set a $230.00 price target on shares of Danaher in a research note on Monday, July 6th. Rothschild & Co Redburn set a $205.00 price target on Danaher in a report on Friday, April 17th. Finally, HSBC lowered their price objective on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. One research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $231.64.
Check Out Our Latest Research Report on Danaher
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
- Five stocks we like better than Danaher
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
